Global Fetal Bovine Serum Market
Pharmaceuticals

Global Insights: Fetal Bovine Serum Market Expected to Surpass $1.31 Billion by 2029

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Fetal Bovine Serum Industry?

The market size of fetal bovine serum has seen a consistent increase in the past few years. The monetary value of the market is projected to rise from $1.02 billion in 2024 to $1.06 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.6%. The growth observed during the historical period is linked to the expansion of the biopharmaceutical industry, augmentation in cell-based therapies, and requirements for quality and consistency.

In the upcoming years, a robust expansion is foreseen in the market of fetal bovine serum, as it is predicted to reach a staggering $1.31 billion by 2029, growing annually at a compound rate of 5.4%. This growth during the projection period can be ascribed to the increased adoption of cell-based therapies, the advent of sophisticated therapeutics, the emphasis on alternatives that don’t utilize animals, and enhanced relationships between suppliers and clients. Key market trends for this period consist of a focus on quality and traceability, international collaborations and partnerships, strategic mergers and acquisitions, fetal bovine serum products tailored to specific needs, and adherence to regulations and ethical sourcing practices.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=4109&type=smp

#Which Factors Are Currently Driving The Growth Of The Fetal Bovine Serum Market?

The forecast period is expected to witness a surge in the fetal bovine serum market, as a result of increased demand for biopharmaceuticals. The basic element of biopharmaceuticals, which are medicinal substances synthesized from biological entities like animals, humans, and microorganisms through biotechnology, is Fetal bovine serum (FBS). It serves as a common alternative for animal cell culture media. Many pharmaceutical companies, diagnostic labs, and researchers heavily depend on FBS for their cell culture needs in the study of biologics. In 2022, the sales of pharmaceuticals and vaccines segments of ProClinical Limited, a lifesciences service and consulting firm stationed in the UK, amounted to US$36.15mn, marking an 11% year-over-year increase. Hence, the escalating need for biopharmaceuticals is fueling the growth of the fetal bovine serum market.

The fetal bovine serum market covered in this report is segmented –

1) By Product: Charcoal Stripped, Chromatographic, Dialyzed Fetal Bovine Serum, Exosome Depleted, Stem Cell, Other Products

2) By Application: Drug Discovery, Cell Culture Media, In Vitro Fertilization, Human And Animal Vaccine Production, Diagnostics, Other Applications

3) By End-User: Research And Academic Institutes, Biotechnology And Pharmaceutical Industry, Other End-Users

Subsegments:

1) By Charcoal Stripped: Standard Charcoal Stripped FBS, Heat-Inactivated Charcoal Stripped FBS

2) By Chromatographic: Ion Exchange Chromatography Purified FBS, Affinity Chromatography Purified FBS

3) By Dialyzed Fetal Bovine Serum: Standard Dialyzed FBS, Heat-Inactivated Dialyzed FBS

4) By Exosome Depleted: Standard Exosome Depleted FBS, Heat-Inactivated Exosome Depleted FBS

5) By Stem Cell: Stem Cell Grade FBS, Knockout Serum Replacement

6) By Other Products: Serum from Specific Animal Breeds, Custom-Processed FBS

What Trends Are Currently Influencing Growth In The Fetal Bovine Serum Market?

Growing partnerships between corporations and research institutions are becoming a prominent trend in the fetal bovine serum market. Major businesses are working together to enhance manufacturing capacities, grow their market presence, and create new products. For example, GE Healthcare, a US company, collaborated with Oritain, a New Zealand firm, to develop an autonomous test to verify the country of origin of fetal bovine serum (FBS). This will assist biomanufacturing organizations as FBS used in various nations present diverse risk levels for virus contamination.

Who Are The Main Participants Shaping The Fetal Bovine Serum Market Landscape?

Major companies operating in the fetal bovine serum market include Thermo Fisher Scientific Inc., Merck KGaA, Corning Incorporated, Cytiva, VWR International, Sartorius AG, Bio-Techne Corporation, Atlas Biologicals Inc., R&D Systems Inc., Atlanta Biologicals Inc., Cyagen Biosciences, GenClone Inc., Gemini Bio-Products, Access Biologicals LLC, Nucleus Biologics, ZenBio Inc., Biowest, Bovogen Biologicals Pty Ltd., TCS Biosciences Ltd., J R Scientific Inc., Rocky Mountain Biologicals Inc., Tissue Culture Biologicals, Moregate Biotech, Cell Applications Inc., Altogen Biosystems, Axil Scientific Pte Ltd., Animal Technologies Inc., PAN- Biotech, PAA Laboratories GmbH, Peak Serum Inc.

https://www.thebusinessresearchcompany.com/report/fetal-bovine-serum-global-market-report

Which Region Currently Holds The Largest Share In The Fetal Bovine Serum Market?

North America was the largest region in the fetal bovine serum market in 2024. Asia-Pacific recorded the fastest growth during the forecast period. The regions covered in the fetal bovine serum market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=4109&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model